WK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy now for a near-term rebound setup: WK is trading near key support (S1 ~75.50) with a very oversold short-term RSI (RSI_6 ~26), while options positioning is notably call-skewed and Wall Street remains broadly bullish with recent price-target hikes (roughly $98–$115) and a fresh $105 Buy initiation. The main pushback is that momentum is still bearish (MACD histogram negative and expanding) and hedge funds have been selling aggressively, but at ~$77 the risk/reward is favorable for an impatient buyer looking for an entry rather than waiting for a perfect technical turn.
Trend/momentum: Bearish-to-basing. MACD histogram is -0.794 and negatively expanding, signaling downside momentum is still in control.
Overbought/oversold: RSI_6 26 indicates a strongly oversold short-term condition (rebound-prone).
Levels: Price 77.02 is below the pivot (80.316). Nearby support sits at S1 75.503 (close) then S2 72.53; resistance levels are 85.13 (R1) then 88.103 (R2).
Moving averages: Converging MAs suggest the selloff may be transitioning into a base, but confirmation requires reclaiming the pivot zone (80–81).
Intellectia Proprietary Trading Signals:
Intellectia Proprietary Trading Signals
on 2026-02-19 after hours could re-rate the stock if execution/margins track the long-term targets.
Technical pressure remains: MACD is bearish and still worsening; price is below the pivot (~80.3), so the path of least resistance is not yet clearly up.
Positioning/flows: Hedge funds are net sellers, with selling amount up ~288% over the last quarter.
Profitability volatility: 2025/Q3 net income and EPS declined sharply YoY (despite revenue growth), which can keep skepticism elevated until profitable growth is more consistent.
No near-term news catalysts: No notable news in the past week to force an immediate sentiment reversal.
Latest quarter: 2025/Q3. Growth: Revenue rose to $224.166M (+20.77% YoY), indicating strong top-line momentum. Profitability: Net income fell to ~$2.786M (down ~116% YoY) and EPS to $0.05 (down ~116% YoY), showing earnings are currently noisy/pressured despite growth. Quality of revenue: Gross margin improved to 79.31% (+3.71% YoY), a constructive sign that the model is scaling even if bottom-line results are not yet consistently compounding. Other notable holders/insiders/politicians: Insiders are neutral recently; no recent Congress trading data available in the last 90 days.
Recent trend: Ratings and targets have moved higher and remain predominantly bullish. Key changes: Multiple firms raised price targets after Q3 (e.g., Truist to $110, Baird to $115, Goldman to $110, Stephens to $100, BMO to $103, Stifel to $98). BTIG initiated coverage (2025-12-16) with Buy and a $105 target. Wall Street pros: Durable subscription growth (~20%), sticky platform, multi-solution adoption, improving margins, and confidence in longer-term targets. Wall Street cons: Macro/regulatory uncertainty and the need to prove consistent profitable growth (earnings volatility versus revenue strength).
